Celon Pharma SA Cash Flow-to-Debt Ratio
Celon Pharma SA cash flow-to-debt ratio. Celon Pharma SA (CLN) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2026, meaning its operating cash flow of zł-4.79 Million could theoretically repay 0% of its total liabilities (zł141.95 Million) in one year. Check how aggressively does Celon Pharma SA reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Celon Pharma SA (2012–2025)
Cash flow-to-debt ratio of Celon Pharma SA from 2012 to 2025. Historical debt coverage capacity for Celon Pharma SA across 14 annual periods. Check Celon Pharma SA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Celon Pharma SA Cash Flow-to-Debt Ratio by Year (2012–2025)
Celon Pharma SA cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Celon Pharma SA. For the full cash flow conversion analysis, see Celon Pharma SA operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | zł23.86 Million | zł74.47 Million | ▲ +378.6% |
| 2024 | -0.12x | zł-11.34 Million | zł98.59 Million | ▼ -71.2% |
| 2023 | -0.07x | zł-8.31 Million | zł123.75 Million | ▼ -84.8% |
| 2022 | -0.04x | zł-4.70 Million | zł129.29 Million | ▼ -112.7% |
| 2021 | 0.29x | zł43.95 Million | zł153.14 Million | ▲ +8.9% |
| 2020 | 0.26x | zł70.90 Million | zł268.97 Million | ▲ +863.6% |
| 2019 | -0.03x | zł-5.05 Million | zł146.31 Million | ▼ -114.1% |
| 2018 | 0.25x | zł28.24 Million | zł114.94 Million | ▼ -17.3% |
| 2017 | 0.30x | zł25.30 Million | zł85.20 Million | ▼ -11.1% |
| 2016 | 0.33x | zł20.65 Million | zł61.82 Million | ▼ -57.0% |
| 2015 | 0.78x | zł52.37 Million | zł67.47 Million | ▲ +14.1% |
| 2014 | 0.68x | zł24.36 Million | zł35.82 Million | ▲ +144.6% |
| 2013 | 0.28x | zł8.45 Million | zł30.39 Million | ▼ -69.3% |
| 2012 | 0.90x | zł12.87 Million | zł14.22 Million | — |